April 25, 2022
COVID-19 Health Care Fraud Enforcement on the Rise: What’s Ahead for the Life Sciences & Healthcare Industries
March 28, 2022
AdvaMed Updates Code of Ethics on Interactions with HCPs: What’s the Impact on MedTech?
March 21, 2022
Chambers Global Practice Guide: Pharmaceutical Advertising 2022
August 17, 2021
Revised PhRMA Code Provides Stricter Controls on HCP Speaker Programs
March 19, 2021
Pharmaceutical Advertising
March 11, 2021
Biden Administration - What's Ahead for the Life Sciences Industry?
February 3, 2021
Implementation of Final Rule Excluding PBM Rebates from Discount Safe Harbor Delayed Until 2023
January 15, 2021
General Counsel Internal Investigations Decision Tree for the Life Sciences Industry
December 17, 2020
CMS Proposes New DMEPOS Coverage Policies and Payment Rates, and Seeks to Codify HCPCS Application, Benefit Category and Payment Determination Processes
November 25, 2020
HHS Finalizes Rule Challenging Drug Manufacturer Rebates to PBMs and Payors
November 24, 2020
Are Pharma Speaker Programs Facing an Existential Crisis?